Abstract
2′-fucosyllactose (2′-FL), one of the simplest but most abundant oligosaccharides in human milk, has been demonstrated to have many positive benefits for the healthy development of newborns. However, the high-cost production and limited availability restrict its widespread use in infant nutrition and further research on its potential functions. In this study, on the basis of previous achievements, we developed a powerful cell factory by using a lacZ-mutant Escherichia coli C41 (DE3)ΔZ to ulteriorly increase 2′-FL production by feeding inexpensive glycerol. Initially, we co-expressed the genes for GDP-L-fucose biosynthesis and heterologous α-1,2-fucosyltransferase in C41(DE3)ΔZ through different plasmid-based expression combinations, functionally constructing a preferred route for 2′-FL biosynthesis. To further boost the carbon flux from GDP-L-fucose toward 2′-FL synthesis, deletion of chromosomal genes (wcaJ, nudD, and nudK) involved in the degradation of the precursors GDP-L-fucose and GDP-mannose were performed. Notably, the co-introduction of two heterologous positive regulators, RcsA and RcsB, was confirmed to be more conducive to GDP-L-fucose formation and thus 2′-FL production. Further a genomic integration of an individual copy of α-1,2-fucosyltransferase gene, as well as the preliminary optimization of fermentation conditions enabled the resulting engineered strain to achieve a high titer and yield. By collectively taking into account the intracellular lactose utilization, GDP-L-fucose availability, and fucosylation activity for 2′-FL production, ultimately a highest titer of 2′-FL in our optimized conditions reached 6.86 g/L with a yield of 0.92 mol/mol from lactose in the batch fermentation. Moreover, the feasibility of mass production was demonstrated in a 50-L fed-batch fermentation system in which a maximum titer of 66.80 g/L 2′-FL was achieved with a yield of 0.89 mol 2′-FL/mol lactose and a productivity of approximately 0.95 g/L/h 2′-FL. As a proof of concept, our preliminary 2′-FL production demonstrated a superior production performance, which will provide a promising candidate process for further industrial production.
Highlights
Breast-feeding has long been considered the preferred option for infant nutrition, since human milk contains a large number of bioactive nutrients that are not available and indispensable (Bode, 2012)
E. coli C41 (DE3) Z deficient in β-galactosidase was previously constructed by Dr Jinyong Wu in our laboratory, and used as the host strains for 2′-FL production in this study
The knockout of nudD gene generated an improved GDP-L-fucose concentration in C41 ZWK/pR (Supplementary Figure 3), and a maximum titer of 2′-FL was appreciably increased to 3.55 g/L (Figure 3B), which was 23.7% higher than that detected in the control strain C41 ZW/pR
Summary
Breast-feeding has long been considered the preferred option for infant nutrition, since human milk contains a large number of bioactive nutrients that are not available and indispensable (Bode, 2012). Therein, human milk oligosaccharides (HMOs) provide a wide range of biological functions for infant care, for instance, improvement of infant digestion and intestinal development, promotion of infant brain development, and immune maturation (Bode, 2012; Donovan and Comstock, 2016; Reverri et al, 2018). As a naturally-occurring ingredient with a high content in human breast milk, 2′-FL is almost absent in cow’s milk which is the most commonly used raw material for infant formula (Petschacher and Nidetzky, 2016). Industrial 2′-FL production cost-effectively has attracted more and more attention, and has become the focus of competition in patent protection worldwide
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.